Cabot's (CBT) Hold (C) Rating Reiterated at Weiss Ratings

Key Points

• Cabot Corporation (NYSE: CBT) has had its "hold (c)" rating reiterated by Weiss Ratings, with consensus analysts indicating a general sentiment of holding the stock.
• In recent trading, Cabot's stock was priced at $73.03, reflecting a decline, while the company's 52-week range is between $70.40 and $117.46.
• Cabot reported $1.90 earnings per share for the last quarter, surpassing analysts' expectations, but with revenue falling short of estimates at $923 million.

Cabot (NYSE:CBT - Get Free Report)'s stock had its "hold (c)" rating reissued by analysts at Weiss Ratings in a research note issued to investors on Wednesday,Weiss Ratings reports.

A number of other research firms also recently issued reports on CBT. UBS Group set a $82.00 price objective on shares of Cabot and gave the stock a "neutral" rating in a report on Tuesday, August 5th. Mizuho lowered their price target on shares of Cabot from $90.00 to $88.00 and set an "outperform" rating for the company in a research note on Friday, October 3rd. One equities research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $85.00.

Cabot Price Performance

Shares of NYSE CBT traded down $0.37 during mid-day trading on Wednesday, reaching $73.03. 276,247 shares of the company were exchanged, compared to its average volume of 411,771. Cabot has a 52 week low of $70.40 and a 52 week high of $117.46. The company has a quick ratio of 1.41, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $3.89 billion, a PE ratio of 9.55 and a beta of 0.88. The company's 50 day moving average price is $78.20 and its 200 day moving average price is $77.45.

Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.80 by $0.10. Cabot had a net margin of 11.14% and a return on equity of 25.68%. The company had revenue of $923.00 million during the quarter, compared to the consensus estimate of $957.29 million. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. Sell-side analysts forecast that Cabot will post 7.57 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Sean D. Keohane sold 114,436 shares of the business's stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the transaction, the chief executive officer owned 361,518 shares in the company, valued at $28,661,147.04. The trade was a 24.04% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 3.03% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Cabot

Several hedge funds have recently bought and sold shares of the business. American Century Companies Inc. boosted its stake in Cabot by 11.1% during the second quarter. American Century Companies Inc. now owns 1,664,728 shares of the specialty chemicals company's stock worth $124,855,000 after acquiring an additional 166,460 shares in the last quarter. Bank of America Corp DE boosted its stake in Cabot by 2.0% during the second quarter. Bank of America Corp DE now owns 1,620,440 shares of the specialty chemicals company's stock worth $121,533,000 after acquiring an additional 31,947 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Cabot by 8.2% during the first quarter. Dimensional Fund Advisors LP now owns 1,426,693 shares of the specialty chemicals company's stock worth $118,606,000 after acquiring an additional 108,397 shares in the last quarter. Geode Capital Management LLC boosted its stake in Cabot by 1.8% during the second quarter. Geode Capital Management LLC now owns 1,421,934 shares of the specialty chemicals company's stock worth $106,656,000 after acquiring an additional 25,717 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its stake in Cabot by 1.7% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,190,886 shares of the specialty chemicals company's stock worth $99,010,000 after acquiring an additional 19,333 shares in the last quarter. Institutional investors own 93.18% of the company's stock.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.